期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Early mortality and safety after transcatheter aortic valve replacement using the SAPIEN 3 in nonagenarians 被引量:2
1
作者 Eiji Ichimoto Adam Arnofsky +2 位作者 michael wilderman Richard Goldweit Joseph De Gregorio 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2018年第6期387-393,共7页
Background Transcatheter aortic valve replacement (TAVR) has been performed for many elderly patients with severe aortic stenosis (AS). The SAPIEN 3 is one of the latest balloon-expandable prosthesis. This study a... Background Transcatheter aortic valve replacement (TAVR) has been performed for many elderly patients with severe aortic stenosis (AS). The SAPIEN 3 is one of the latest balloon-expandable prosthesis. This study aimed to investigate the early clinical outcomes after TAVR using the SAPIEN 3 in nonagenarians. Methods A total of 97 consecutive patients underwent TAVR for severe AS between De- cember 2015 and December 2016. Of these, 85 consecutive patients who underwent TAVR using the SAPIEN 3 were included. According to the age, patients were classified into age 〉 90 years group (17 patients) or age 〈 90 years group (68 patients). The clinical outcomes in- cluding all-cause mortality and composite endpoint of early safety at 30 days were evaluated. Results The Society of Thoracic Surgeons score in age 〉 90 years group was higher than age 〈 90 years group (12.3 ±6.1% vs. 8.5 ± 5.1%, P 〈 0.01). There was no significant difference in 30-day mortality between the two groups. However, the life-threatening bleeding and major vascular complications in age 〉 90 years group were greater than age 〈 90 years group (11.8% vs. 1.5%, P = 0.04 and 11.8% vs. 1.5%, P = 0.04, respectively). The composite endpoint of early safety at 30 days was similar between the two groups. Multivariate logistic regression analysis showed that prior myocardial infarction was an independent predictor of the composite endpoint of early safety (odds ratio: 4.76, 95% confidence interval: 1.02-22.21, P = 0.047). Conclusions The early mortality and safety after TAVR using the SAPIEN 3 in nonagenarians were similar and acceptable despite of higher operative risk. 展开更多
关键词 NONAGENARIANS SAPIEN 3 Transcatheter aortic valve replacement
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部